Why Raptor Pharmaceutical Corp. Plunged 13.1% in February – Motley Fool

Why Raptor Pharmaceutical Corp. Plunged 13.1% in February
Motley Fool
What: Shares of Raptor Pharmaceuticals (NASDAQ:RPTP), a biopharmaceutical company that focuses on creating treatments for rare diseases, had a rough February, as the company’s stock lost 13.1% of its value during the month, according to data fromĀ …

and moreĀ >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd